International Stem Cell (ISCO) Preferred Shares (2010 - 2026)
International Stem Cell's (ISCO) quarterly Preferred Shares came in at $5000.0 in Q2 2026, little changed year-over-year from $5000.0 in Q2 2025, and little changed quarter-over-quarter from $5000.0 in Q4 2025.
Analysis
International Stem Cell (ISCO) Preferred Shares (2010 - 2026) Analysis & Trends
International Stem Cell (ISCO) has reported Preferred Shares for 17 consecutive years, with $5000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Preferred Shares changed 0.0% year-over-year to $5000.0 in Q2 2026; TTM through Jun 2026 was $5000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $5000.0, changed 0.0% from the prior year.
- Preferred Shares was $5000.0 for Q2 2026 at International Stem Cell, roughly flat from $5000.0 in the prior quarter.
- Over five years, Preferred Shares peaked at $5000.0 in Q1 2022 and troughed at $5000.0 in Q1 2022.
- A 5-year average of $5000.0 and a median of $5000.0 in 2022 frame the typical range for Preferred Shares.
- The widest YoY moves for Preferred Shares: up 0.0% in 2022, down 0.0% in 2022.
- Over 5 years, Preferred Shares stood at $5000.0 in 2022, then changed by 0.0% to $5000.0 in 2023, then changed by 0.0% to $5000.0 in 2024, then changed by 0.0% to $5000.0 in 2025, then changed by 0.0% to $5000.0 in 2026.
- The last three Preferred Shares figures came in at $5000.0 (Q2 2026), $5000.0 (Q4 2025), and $5000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 2,000.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | International Stem Cell | 2.84 Mn | 1.75 Mn | 1.46 Mn | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | 5,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 5,000.00 |